Qi Cao Selected Research

Qi Cao Research Topics

Disease

65	Neoplasms (Cancer) 05/2022 - 07/2006
36	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 09/2003
23	Inflammation (Inflammations) 01/2022 - 03/2004
20	Fibrosis (Cirrhosis) 01/2021 - 10/2003
17	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2006
14	Renal Cell Carcinoma (Grawitz Tumor) 11/2020 - 01/2017
11	Infections 12/2021 - 02/2014
8	Carcinogenesis 01/2022 - 11/2005
7	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2003
6	Atherosclerosis 08/2022 - 01/2017
6	Proteinuria 01/2022 - 09/2008
6	Kidney Diseases (Kidney Disease) 01/2020 - 07/2013
6	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 04/2002
5	Cardiovascular Diseases (Cardiovascular Disease) 08/2022 - 01/2018
5	Insulin Resistance 01/2019 - 03/2004
5	Alcoholic Fatty Liver 01/2012 - 03/2004
4	Bites and Stings (Sting) 12/2022 - 01/2021
4	Glomerulonephritis 01/2022 - 12/2007
4	Necrosis 01/2022 - 05/2002
4	Lung Neoplasms (Lung Cancer) 01/2022 - 07/2009
4	Pneumonia (Pneumonitis) 01/2021 - 11/2017
4	Chronic Renal Insufficiency 01/2021 - 05/2012
4	Reperfusion Injury 01/2021 - 01/2018
4	Fatty Liver 01/2020 - 03/2008
4	Kidney Neoplasms (Kidney Cancer) 01/2019 - 01/2017
4	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2012 - 12/2002
4	Ovarian Neoplasms (Ovarian Cancer) 04/2009 - 07/2006
3	Acute Kidney Injury (Acute Renal Failure) 04/2022 - 12/2006
3	Hypoxia (Hypoxemia) 01/2022 - 04/2009
3	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 12/2021 - 10/2016
3	Obesity 02/2020 - 01/2017
3	Glioma (Gliomas) 11/2019 - 12/2015
3	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 11/2019 - 12/2007
3	Nephrosis 10/2013 - 06/2008
2	Hemorrhage 01/2022 - 05/2017
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2022 - 03/2012
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2021 - 05/2010

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2003
21	CytokinesIBA 04/2022 - 05/2002
17	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2008
16	Messenger RNA (mRNA)IBA 01/2021 - 03/2004
10	Biological ProductsIBA 01/2021 - 08/2006
8	Long Noncoding RNAIBA 07/2021 - 07/2011
8	AndrogensIBA 01/2021 - 08/2007
7	RNA (Ribonucleic Acid)IBA 08/2022 - 07/2011
7	LipidsIBA 05/2022 - 01/2018
7	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 01/2017
7	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 10/2009
6	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 02/2013
6	Ethanol (Ethyl Alcohol)IBA 01/2022 - 12/2002
6	CateninsIBA 01/2021 - 01/2016
6	CollagenIBA 01/2020 - 01/2006
6	MicroRNAs (MicroRNA)IBA 04/2019 - 06/2011
6	Insulin (Novolin)FDA Link 01/2019 - 03/2004
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2018 - 12/2002
5	Therapeutic UsesIBA 01/2021 - 09/2010
5	Transcription Factors (Transcription Factor)IBA 01/2020 - 07/2010
5	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2019 - 06/2008
5	AntigensIBA 01/2019 - 02/2013
5	Phosphotransferases (Kinase)IBA 01/2019 - 07/2006
4	EnzymesIBA 12/2022 - 03/2008
4	Pharmaceutical PreparationsIBA 08/2022 - 11/2011
4	Estrogens (Estrogen)FDA Link 01/2022 - 11/2006
4	Hormones (Hormone)IBA 01/2021 - 11/2008
4	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 01/2014
4	Polycomb-Group ProteinsIBA 10/2020 - 09/2003
4	Sunitinib (Sutent)FDA Link 09/2020 - 01/2017
4	VaccinesIBA 09/2020 - 12/2008
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 03/2010
4	LipopolysaccharidesIBA 01/2020 - 05/2012
3	Antiviral Agents (Antivirals)IBA 12/2022 - 01/2021
3	Peptides (Polypeptides)IBA 08/2022 - 05/2020
3	Indicators and Reagents (Reagents)IBA 01/2022 - 10/2018
3	Estrogen ReceptorsIBA 01/2022 - 06/2009
3	Small Interfering RNA (siRNA)IBA 10/2021 - 04/2009
3	fucoidanIBA 09/2021 - 03/2019
3	ICG 001IBA 01/2021 - 01/2018
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 04/2015
3	AntioxidantsIBA 12/2020 - 01/2006
3	ChemokinesIBA 11/2019 - 12/2008
3	Complement System Proteins (Complement)IBA 11/2018 - 06/2012
3	NF-kappa B (NF-kB)IBA 01/2018 - 07/2006
3	Matrix Metalloproteinases (MMPs)IBA 05/2017 - 01/2007
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 07/2009
3	CreatinineIBA 01/2015 - 06/2011
3	Proto-Oncogene Proteins c-etsIBA 10/2012 - 01/2008
3	Progestins (Progestagens)IBA 04/2009 - 11/2006
3	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 10/2007 - 07/2005
3	Tissue Inhibitor of Metalloproteinase-1IBA 01/2007 - 03/2006
2	A-Form DNA (A-DNA)IBA 04/2022 - 11/2021
2	Interleukin-33IBA 01/2022 - 01/2018
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022 - 01/2022
2	Immunoglobulin A (IgA)IBA 01/2022 - 03/2012
2	Imatinib Mesylate (Gleevec)FDA Link 12/2021 - 05/2010
2	celastrol methyl esterIBA 12/2021 - 05/2010

Therapy/Procedure

24	Therapeutics 01/2022 - 12/2007
9	Castration 01/2021 - 06/2017
4	Immunotherapy 11/2021 - 01/2018
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 08/2022 - 01/2017
3	Drug Therapy (Chemotherapy) 10/2021 - 06/2017